ArticleEuropean urology2020

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.

Pedro Isaacsson Velho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.